Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations.
Revenues during the first half of 2024 reached NIS 126 million, alongside an Adjusted EBITDA1of NIS 21 million (Approximately 17% of revenues).Both quarters (Q1 and Q2 of 2024) ended with positive...
InterCure expands its European footprint to launch Cookies Corners licensed pharmacies in Germany alongside differentiated online platforms with the official cookies retail experience, enhancing...
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will participate in the Canaccord Genuity 8th...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1 | -7.14285714286 | 1.4 | 1.44 | 1.3 | 28024 | 1.38202944 | CS |
4 | -0.44 | -25.2873563218 | 1.74 | 1.78 | 1.17 | 56094 | 1.39242884 | CS |
12 | -0.72 | -35.6435643564 | 2.02 | 2.07 | 1.17 | 32526 | 1.58699076 | CS |
26 | -1.62 | -55.4794520548 | 2.92 | 3.0019 | 1.17 | 32165 | 1.89605764 | CS |
52 | 0.07 | 5.69105691057 | 1.23 | 3.72 | 1.17 | 52377 | 2.0075594 | CS |
156 | -5.88 | -81.8941504178 | 7.18 | 8.2 | 0.99 | 52116 | 3.61518859 | CS |
260 | -39.2 | -96.7901234568 | 40.5 | 40.5 | 0.99 | 48487 | 4.46324794 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales